Weight changes and metformin use in Thai patients with IGT

Patterns of weight changes following the diagnosis of impaired glucose tolerance (IGT) and Metformin use in Thai patients with IGT

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20201201004

Enrollment

250

Registered

2020-12-01

Start date

2020-10-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

weight changes weight impaired glucose tolerance metformin

Interventions

The patients who have 2&#45

hour plasma glucose level between 140&#45

199 after 75 gm glucose ingestion.

Health Services Research

Impaired glucose tolerance patients

Eligibility

Sex/Gender

All

Age

15 Years to 90 Years

Inclusion criteria

Inclusion criteria: 1.Patients who have newly diagnosed with impair glucose tolerance test 2.Age more than 15 years old

Exclusion criteria

Exclusion criteria: 1.Previously diagnosed with diabetes 2.Pregnancy 3.Previously diagnosed with endocrine disorder; Cushing's disease, acromegaly, adrenal insufficiency 4.Taking steroids 5.Incomplete data

Design outcomes

Primary

Measure	Time frame
Body weight at 3, 6 months before and 3,6,12,24 months after the diagnosis ofIGT Body weight scale	—

Secondary

Measure	Time frame
metformin use during the study dosage in milligram	—

Countries

Thailand

Contacts

Public ContactWaralee Chatchomchuan

Theptarin Hospital

waralee@theptarin.com023487000

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026